JG
ABCL icon

Joel Greenblatt’s AbCellera Biologics ABCL Stock Holding History

Joel Greenblatt’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-46,090
Closed -$298K – 1314
2023
Q2 		$298K Sell
46,090
-77,174
-63% -$527K 0.01% 1126
2023
Q1 		$929K Buy
123,264
+7,162
+6% +$65K 0.02% 770
2022
Q4 		$1.18M Buy
116,102
+37,464
+48% +$433K 0.03% 623
2022
Q3 		$778K Buy
+78,638
New +$863K 0.02% 736
2022
Q1 		– Sell
-28,415
Closed -$406K – 1114
2021
Q4 		$406K Sell
28,415
-44,652
-61% -$678K 0.01% 847
2021
Q3 		$1.46M Buy
73,067
+47,579
+187% +$841K 0.06% 382
2021
Q2 		$561K Buy
+25,488
New +$703K 0.02% 653

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Joel Greenblatt's ABCL Position: Q3 2023 in Review

Joel Greenblatt sold out of AbCellera Biologics (ABCL) in Q3 2023, closing a stake of 46,090 shares — an estimated $298K sold.

Joel Greenblatt first reported a position in ABCL in Q2 2021 and held it in 7 quarters. The position peaked at $1.46M in Q3 2021. 138 funds tracked by Wall St. Rank hold ABCL as of Q3 2023.

  • Joel Greenblatt reported no remaining AbCellera Biologics position as of Q3 2023 after selling out during the quarter.
  • Joel Greenblatt sold 46,090 AbCellera Biologics shares in Q3 2023, an estimated $298K.
  • Joel Greenblatt first reported a position in AbCellera Biologics in Q2 2021 and held it in 7 quarters.
  • Joel Greenblatt's AbCellera Biologics position peaked at $1.46M in Q3 2021.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2023.

Based on Gotham Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.